Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  AKT 1/2 inhibitor BAY1125976
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Phase I Dose Escalation Study With an Allosteric AKT 1/2 Inhibitor in Patients
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16447, NCI-2014-00484, 2012-004671-39, NCT01915576
Start Over